info@srobf.cz +420 495 832 176
CZ / EN
O společnosti

TOP TEN ASTRO 2018

1.Stereotactic Ablative Radiation Therapy for the Comprehensive Treatment of Oligometastatic Tumors_SABR-COMET_ Results of a Randomized Trial

2. NRG-RTOG 1016_ Phase III Trial Comparing Radiation_Cetuximab to Radiation_Cisplatin in HPV-related Cancer of the Oropharynx

3.Short Term Androgen Deprivation Therapy Without or With Pelvic Lymph Node Treatment Added to Prostate Bed Only Salvage Radiotherapy_The NRG Oncology_RTOG 0534 SPPORT Trial

4.Randomized Trial Evaluating Radiation following Surgical Excision for Good Risk DCIS_12-Year Report from NRG RTOG 9804

5. FAST Phase III RCT of Radiotherapy Hypofractionation for Treatment of Early Breast Cancer_ 10-Year Results _CRUKE_04_015

6. A Twenty-Year Update on the Outcomes of a Randomized Dose-Escalation Trial for Prostate Cancer

7.10-Year Update of a Randomized Prospective Trial of Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer

8. Patient Reported Outcomes of NRG Oncology_RTOG 0232_A phase III Study Comparing Combined External Beam Radiation

9. Randomized Phase III Trial Comparing Gamma Knife and Linac Based_EDGE_Approaches for Brain Metastases Radiosurgery_Results from the Gadget Trial

10.PACIFIC_Overall Survival with Durvalumab versus Placebo after Chemoradiotherapy in Stage III NSCLC

VÝZNAMNÉ RETROSPEKTIVNÍ STUDIE A METAANALÝZY

1. Cancer-Specific Outcomes of Hypofractionated Locoregional Radiation Therapy for Patients with Stage I-III Breast Cancer

2. Long-Term Survival Comparison of Stereotactic Radiation Therapy Versus Surgery for Elderly Patients with Clinical Stage T1-T2 Non-Small Cell Lung Cancer

3. Comparative Effectiveness of Prostatectomy and Radiation Therapy (RT) in Gleason 9-10 Prostate Cancer

4. Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate Cancer

5.Risk of Radiation Pneumonitis Following Individualized Modern Radiation Therapy with IMRT a Breath-Holding Technique and Prone Positioning for Breast Cancer

6. Is the Importance of Heart Dose Overstated in Non-Small Cell Lung Cancer_A Systematic Review of the Literature

7. Role of Post Mastectomy Radiation Therapy Boost in Invasive Breast Cancer Patients. Is It Needed

8. Initial SRS for Patients with 5-15 Brain Metastases_Results of a Multi-Institutional Experience.

9. A Meta-Analysis of Randomized Trials to Compare the Added Benefit of a Brachytherapy Boost Versus the Addition of Androgen Deprivation Therapy

10. ADT and Dementia in Veterans with Prostate Cancer Treated with Definitive Radiation Therapy

1